SCHEMBL117340

SCHEMBL117340

CC(C)(C)c1cccc(N2CCN(C(C)(C)C)CC2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
SIGMAR1 Q99720 2/20 0.45
HTR3E A5X5Y0 1/20 0.45
HTR3B O95264 1/20 0.45
HTR1D P28221 1/20 0.45
HTR2C P28335 1/20 0.45
HTR3A P46098 1/20 0.45
HTR3D Q70Z44 1/20 0.45
HTR3C Q8WXA8 1/20 0.45
MAPT P10636 2/20 0.44
THRB P10828 1/20 0.44
TSHR P16473 4/20 0.43
ADRA2C P18825 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
NPSR1 Q6W5P4 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
NPC1 O15118 1/20 0.41
MAPK1 P28482 1/20 0.41
LMNA P02545 2/20 0.41
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10294005 0.87 ALDH1A1 (0.62) ALDH1A1SIGMAR1HTR3EHTR3BHTR1D
SCHEMBL11947326 0.84 ADRA2C (0.61) ALDH1A1SIGMAR1HTR3EHTR3BHTR1D
SCHEMBL12017183 0.84 ALDH1A1 (0.49) ALDH1A1SIGMAR1HTR3EHTR3BHTR1D
SCHEMBL271333 0.82 PRMT6 (0.50) ALDH1A1SIGMAR1HTR3EHTR3BHTR1D
SCHEMBL18210659 0.82 PRMT6 (0.50) ALDH1A1SIGMAR1HTR3EHTR3BHTR1D
SCHEMBL10244469 0.81 ADRB1 (0.59) ALDH1A1MAPTL3MBTL1MAPK1LMNA
SCHEMBL30822482 0.81 ADRA2C (0.66) ALDH1A1MAPTTSHRADRA2CSMN1; SMN2
SCHEMBL23510815 0.80 MAPT (0.47) ALDH1A1SIGMAR1HTR3EHTR3BHTR1D
SCHEMBL270532 0.79 HTR3E (0.71) ALDH1A1SIGMAR1HTR3EHTR3BHTR1D
SCHEMBL14349176 0.79 ALDH1A1 (0.45) ALDH1A1SIGMAR1HTR3EHTR3BHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9452997-B2 Piperidine and piperazine derivatives as autotaxin inhibitors MERCK PATENT GMBH (DE) 2016-09-27 US disclosed
US-9452997-B2 Piperidine and piperazine derivatives as autotaxin inhibitors MERCK PATENT GMBH (DE) 2016-09-27 US disclosed
US-20140343075-A1 PIPERIDINE AND PIPERAZINE DERIVATIVES AS AUTOTAXIN INHIBITORS MERCK PATENT GMBH (DE) 2014-11-20 US disclosed
US-20140343075-A1 PIPERIDINE AND PIPERAZINE DERIVATIVES AS AUTOTAXIN INHIBITORS MERCK PATENT GMBH (DE) 2014-11-20 US disclosed
US-8822476-B2 Piperidine and piperazine derivatives as autotaxin inhibitors MERCK PATENT GMBH (DE) 2014-09-02 US disclosed
US-8822476-B2 Piperidine and piperazine derivatives as autotaxin inhibitors MERCK PATENT GMBH (DE) 2014-09-02 US disclosed
US-20120059016-A1 PIPERIDINE AND PIPERAZINE DERIVATIVES AS AUTOTAXIN INHIBITORS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140343075-A1 PIPERIDINE AND PIPERAZINE DERIVATIVES AS AUTOTAXIN INHIBITORS ENPP2, PLA2G12A, PLA2G2E ALDH1A1 2635/4885SIGMAR1 4251/4885HTR3E 2795/4885
US-20120059016-A1 PIPERIDINE AND PIPERAZINE DERIVATIVES AS AUTOTAXIN INHIBITORS ENPP2, PLA2G12A, PLA2G2E ALDH1A1 2635/4885SIGMAR1 4251/4885HTR3E 2795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.